CDKN2A and esophageal adenocarcinoma: Adenomatous Polyposis Coli (APC) promoter methylation is a characteristic of gastrointestinal cancers [84], and hypermethylation of the CDKN2A/p16 promoter leads to its inactivation in esophageal adenocarcinoma.